SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
OBJECTIVES To determine the prevalence and prognostic significance of the SKY92 gene-expression signature, evaluate minimal/measurable residual disease (MRD), and identify molecular drivers of high-risk disease in transplant-eligible newly diagnosed multiple myeloma (TE-NDMM) patients in the Republic of Ireland. METH...